title: Lung function decline in COPD trials.
authors.forename: O N
authors.initials: ON
authors.lastname: Keene
authors.forename: B
authors.initials: B
authors.lastname: Celli
authors.forename: J A
authors.initials: JA
authors.lastname: Anderson
authors.forename: G T
authors.initials: GT
authors.lastname: Ferguson
authors.forename: C R
authors.initials: CR
authors.lastname: Jenkins
authors.forename: P W
authors.initials: PW
authors.lastname: Jones
authors.forename: J
authors.initials: J
authors.lastname: Vestbo
authors.forename: K
authors.initials: K
authors.lastname: Knobil
authors.forename: J C
authors.initials: JC
authors.lastname: Yates
authors.forename: P M A
authors.initials: PM
authors.lastname: Calverley
mesh_terms: D015982:Bias; D003627:Data Interpretation, Statistical; D006801:Humans; D008168:Lung / Q000503:physiopathology*; D010919:Placebos; D029424:Pulmonary Disease, Chronic Obstructive / Q000503:physiopathology* / Q000628:therapy; D015272:Pulmonary Medicine / Q000379:methods / Q000592:standards; D016032:Randomized Controlled Trials as Topic; D012044:Regression Analysis; D012107:Research Design; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D010919:Placebos